---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009390"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2025-03-06T23:59:59+00:00"
generated_at: "2026-05-25T04:58:45.689609+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nephros reports first annual net income; Q4 revenue up 19% YoY to $3.9M

## Summary
- Net income of $74K for FY2024 vs net loss of $1.6M in 2023; first annual profit in company history.
- Q4 net revenue $3.9M (+19% YoY); full-year revenue flat at $14.2M with core programmatic up 9% offset by emergency decline.
- Gross margin improved to 62% for year (vs 59%) due to better supplier terms; SG&A down 14%.
- Added nearly 600 new customer sites (~$2M sales); launched 20" HydraGuard Ultrafilter for sterile processing market.

## SEC filing metadata
- accession: 0001493152-25-009390
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2025-03-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000149315225009390/0001493152-25-009390-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000149315225009390/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009390
- JSON: https://secwatch.observer/filing/0001493152-25-009390.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009390.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.